About
Technology
Issues
FAQ
Links
Official Page
Phase 3 Randomized Study of Daratumumab Plus Bortezomib, Melphalan, and Prednisone (D-VMP) Versus Bortezomib, Melphalan, and Prednisone (VMP) in Newly Diagnosed Multiple Myeloma (NDMM) Patients (Pts) Ineligible for Transplant (ALCYONE)
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.